ONCO

Onconetix, Inc.

Latest Form 4:Sale$34KbyHRT FINANCIAL LP (10% Owner) · filed Apr 22, 2026

Onconetix, Inc. (ONCO) has 3 SEC Form 4 filings (6 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Apr 22, 2026.

The most active filer is 10% Owner HRT FINANCIAL LP with 6 filings.

  • Industry:Biotechnology
  • CEO:David Allan White
  • Employees:8
  • HQ:Cincinnati, OH, US
  • IPO:2022-02-18

Insider Buying

$153K

reported purchases (SEC code P)

Insider Selling

$144K

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Source
Sale$34KApr 22SEC ↗
Sale$39KApr 21SEC ↗
Purchase$25KApr 21SEC ↗
Sale$71KApr 21SEC ↗
Purchase$57KApr 16SEC ↗
Purchase$70KApr 16SEC ↗

Related companies

Onconetix, Inc. is in the Healthcare sector.